Form 144 AVALO THERAPEUTICS For: 29 April
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avalo Therapeutics Inc (AVTX)
Assess today's live Avalo Therapeutics Inc (AVTX) share price, performance and insights using our live NASDAQ: AVTX stock exchange data.
Analyse the historical data and Avalo Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Avalo Therapeutics share price buy/sell indicators using real-time data (or discuss the Avalo Therapeutics (AVTX) stock price today with other investors in the Avalo Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ AVTX share price (ISIN: US05338F3064) to enhance your trading decisions with our free investment tools and resources.
What Is the Avalo Therapeutics Inc Share Price Today?
The Avalo Therapeutics share price today is 13.400.
What Is the Stock Symbol for Avalo Therapeutics Inc
The stock symbol (or 'ticker') for Avalo Therapeutics Inc is "AVTX."
What Stock Exchange Does Avalo Therapeutics Inc Trade On?
Avalo Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Avalo Therapeutics Inc a Good Stock to Buy?
Determining whether Avalo Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Avalo Therapeutics Inc share price performance charts on this page. Our technical summary section provides analysis on Avalo Therapeutics share price buy/sell indicators using real-time data (or discuss the Avalo Therapeutics (AVTX) stock price today with other investors in the Avalo Therapeutics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ AVTX share price (ISIN: US05338F3064) to enhance your trading decisions with our free investment tools and resources.
What Is the Avalo Therapeutics Inc Share Price Today?
The Avalo Therapeutics share price today is 13.400.
What Is the Stock Symbol for Avalo Therapeutics Inc
The stock symbol (or 'ticker') for Avalo Therapeutics Inc is "AVTX."
What Stock Exchange Does Avalo Therapeutics Inc Trade On?
Avalo Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Avalo Therapeutics Inc a Good Stock to Buy?
Determining whether Avalo Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.550
13.575
52 wk Range
3.390
20.720
AVTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.55013.575
52 wk Range
3.39020.720
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AVTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
40.091
Upside
+199.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
- Cerecor Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Form 144 AVALO THERAPEUTICS For: 29 April
- Investing.com
- Form DEF 14A Avalo Therapeutics Inc For: 22 April
- Investing.com
- Form S-1 Avalo Therapeutics Inc For: 17 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell
Analyst Ratings
13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 40.091
(+199.19% Upside)
Earnings
Latest Release
23/03/2026
EPS / Forecast
-0.75 / -1.25
Revenue / Forecast
59K / --
Compare AVTX to Peers and Sector
Metrics to compare | AVTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.6x | −2.6x | −0.5x | |
PEG Ratio | −0.06 | −0.07 | 0.00 | |
Price/Book | 4.3x | 2.0x | 2.6x | |
Price / LTM Sales | 6,067.3x | 55.2x | 3.2x | |
Upside (Analyst Target) | 198.5% | 237.1% | 48.8% | |
Fair Value Upside | Unlock | 14.8% | 6.9% | Unlock |
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Wayne, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Avalo Therapeutics (NASDAQ: AVTX) Share Price Today?
The Avalo Therapeutics stock price today is 13.400 USD.
What Stock Exchange Does Avalo Therapeutics (AVTX) Trade On?
Avalo Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Avalo Therapeutics?
The stock symbol (also called a 'ticker') for Avalo Therapeutics is "AVTX."
What Is the Current Avalo Therapeutics Market Capitalisation?
As of today, Avalo Therapeutics (NASDAQ: AVTX) market cap is 357.970M USD.
What Is Avalo Therapeutics's (AVTX) Earnings Per Share (TTM)?
The Avalo Therapeutics EPS is currently -5.840 (Trailing Twelve Months).
Is AVTX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Avalo Therapeutics moving averages and other technical indicators, the daily buy/sell signal for AVTX stock is Strong Sell.
How Many Times Has Avalo Therapeutics Stock Split?
Avalo Therapeutics has split 2 times. (See the AVTX stock split history page for full effective split date and price information.)
How Many Employees Does Avalo Therapeutics Have?
Avalo Therapeutics has 33 employees, based on their latest Companies House report.
What is the current trading status of Avalo Therapeutics (NASDAQ: AVTX)?
As of 01/05/2026, Avalo Therapeutics (AVTX) is trading at a share price of 13.400 USD, with a previous close of 13.400 USD. The stock has fluctuated within a day range of 12.550 USD to 13.575 USD, while its 52-week range spans from 3.390 USD to 20.720 USD.
What Is Avalo Therapeutics (AVTX) Price Target According to Analysts?
The average 12-month price target for Avalo Therapeutics is 40.091 USD, with a high estimate of 52 USD and a low estimate of 24 USD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +199.19% Upside potential.
What Is the AVTX After Hours Price?
AVTX's last after hours stock price is 13.240 USD, the stock has decreased by -0.160, or -1.190%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.